MARKET

EDAP

EDAP

Edap Tms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.96
-0.09
-1.28%
Opening 10:51 06/24 EDT
OPEN
7.00
PREV CLOSE
7.05
HIGH
7.06
LOW
6.96
VOLUME
13.42K
TURNOVER
--
52 WEEK HIGH
10.68
52 WEEK LOW
2.250
MARKET CAP
203.21M
P/E (TTM)
497.14
1D
5D
1M
3M
1Y
5Y
EDAP's subsidiary names medTech industry veteran Ryan Rhodes as CEO
EDAP Technomed, the US subsidiary of EDAP TMS (EDAP) has appointed medical technology industry veteran Ryan Rhodes as Chief Executive Officer to drive EDAP’s US expansion focus.Mr. Rhodes, most recently served as Chief Commercial Officer
Seekingalpha · 06/15 12:33
BRIEF-EDAP Announces Hiring Of MedTech Industry Veteran Ryan Rhodes As CEO Of Company’s U.S. Subsidiary
reuters.com · 06/15 12:26
EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary
Appointment brings highly experienced medical technology and commercialization leader to drive EDAP’s US expansion focus.Career accomplishments include 14 years at Intuitive Surgical, where he played a leading role in global clinical expansion of robotic s...
GlobeNewswire · 06/15 12:00
Results: EDAP TMS S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
EDAP TMS S.A. ( NASDAQ:EDAP ) shareholders are probably feeling a little disappointed, since its shares fell 4.1% to...
Simply Wall St. · 05/13 05:43
EDAP TMS SA to Host Earnings Call
May 12, 2021 (ACCESSWIRE via COMTEX) -- NEW YORK, NY / ACCESSWIRE / May 12, 2021 / EDAP TMS SA (NASDAQ:EDAP) will be discussing their earnings results in...
ACCESSWIRE · 05/12 10:45
Recap: Edap TMS Q1 Earnings
Shares of Edap TMS (NASDAQ:EDAP) rose after the company reported Q1 results. Quarterly Results Earnings per share increased 160.00% year over year to $0.03, which beat the estimate of ($0.01).
Benzinga · 05/11 20:57
BRIEF-Edap Reports First Quarter 2021 Results And Provides Operational Update
reuters.com · 05/11 20:53
Edap TMS Q1 EPS $0.03 Beats $(0.01) Estimate, Sales $12.35M Miss $12.68M Estimate
Edap TMS (NASDAQ:EDAP) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.01) by 400 percent. This is a 160 percent increase over losses of $(0.05) per share from the same
Benzinga · 05/11 20:48
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EDAP. Analyze the recent business situations of Edap Tms through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EDAP stock price target is 13.16 with a high estimate of 14.90 and a low estimate of 11.92.
EPS
Institutional Holdings
Institutions: 54
Institutional Holdings: 6.37M
% Owned: 21.81%
Shares Outstanding: 29.20M
TypeInstitutionsShares
Increased
6
1.40M
New
16
716.09K
Decreased
8
809.65K
Sold Out
4
56.06K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+0.36%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Chairman/Chief Executive Officer/Director
Marc Oczachowski
Chief Financial Officer
Francois Dietsch
Director
Marie Meynadier
Independent Director
Pierre Beysson
Independent Director
Robrecht Michiels
Independent Director
Rob Michiels
Independent Director
Argil Wheelock
No Data
About EDAP
EDAP TMS S.A. (EDAP) is a company that develops, manufactures, promotes and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. The Company operates worldwide via an extensive network of corporate offices, subsidiaries and distribution partners. The Company invests in Research & Development, partnering with INSERM French public laboratory and international medical research institutions. Company's activity is organized in two divisions: HIFU and UDS (including lithotripsy activities). The Company is developing HIFU technology (High Intensity Focused Ultrasound) in non-invasive treatment of prostate conditions with its range of Robotic HIFU devices, Ablatherm Fusion and Focal One. The Company is also developing ESWL (Extracorporeal ShockWave Lithotripsy) and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications.

Webull offers kinds of Edap Tms SA (ADR) stock information, including NASDAQ:EDAP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDAP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EDAP stock methods without spending real money on the virtual paper trading platform.